{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-25-000630","form_type":"8-K","ticker":"ARCT","cik":"0001768224","company_name":"Arcturus Therapeutics Holdings Inc.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.636949+00:00","generated_at":"2026-05-22T00:05:21.458700+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcturus Q1 net loss narrows to $14.1M; cash runway extends into 2028","bullets":["Net loss $14.1M ($0.52/diluted share) vs $26.8M ($1.00) a year ago; revenue $29.4M down 23% YoY.","Cash, equivalents and restricted cash $273.8M at March 31, 2025; runway extended into 2028 via resource re-allocation.","Received initial EU approval milestone payment from CSL Seqirus for KOSTAIVE COVID-19 vaccine.","ARCT-032 (CF) Phase 2 interim data from first two cohorts expected mid-2025; enrollment to complete by year-end.","ARCT-810 (OTC) Phase 2 interim data expected Q2 2025; FDA Fast Track granted for H5N1 vaccine ARCT-2304."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-25-000630","json":"https://secwatch.observer/filing/0001193805-25-000630.json","markdown":"https://secwatch.observer/filing/0001193805-25-000630.md","text":"https://secwatch.observer/filing/0001193805-25-000630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525000630/0001193805-25-000630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525000630/e664482_8k-arct.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T00:05:21.458700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}